Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Emily G. Caggiano

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6729-120X; OpenAlex author ID A5023698123. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

  1. UCP2 and pancreatic cancer: conscious uncoupling for therapeutic effect. Co-author DOI 10.1007/s10555-023-10157-4↗
  2. Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment. Co-author DOI 10.1053/j.gastro.2022.02.024↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Cullen M. Taniguchi · 2 shared papers, 2022–2024 · strength 0.57
  2. Abagail M. Delahoussaye · 1 shared paper, 2022 · strength 0.12
  3. Carolina J. García García · 1 shared paper, 2022 · strength 0.12
  4. Natividad Roberto Fuentes · 1 shared paper, 2022 · strength 0.12
  5. Tara N. Fujimoto · 1 shared paper, 2022 · strength 0.12
  6. Meifang Yu · 1 shared paper, 2022 · strength 0.12
  7. Nicholas D. Nguyen · 1 shared paper, 2022 · strength 0.12
  8. Maria E. Monberg · 1 shared paper, 2022 · strength 0.12
  9. Jaewon James Lee · 1 shared paper, 2022 · strength 0.12
  10. Jun Zhao · 1 shared paper, 2022 · strength 0.12
  11. Vincent Bernard · 1 shared paper, 2022 · strength 0.12
  12. Daniel Lin · 1 shared paper, 2022 · strength 0.12
  13. Anirban Maitra · 1 shared paper, 2022 · strength 0.12
  14. Dieter Saur · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.